Harbour reports results from HCC combo therapy trial

Harbour reports results from HCC combo therapy trial

Submitted by admin on May 29, 2023 - 12:23pm
Source: 
Clinical Trials Arena
News Tags: 
Harbour BioMed
porustobart
HCC
hepatocellular carcinoma
clinlcal trials
Headline: 
Harbour reports results from HCC combo therapy trial
snippet: 

Harbour BioMed has reported results from a Phase Ib clinical trial of porustobart (HBM4003) combined with toripalimab for the treatment of hepatocellular carcinoma (HCC).

Do Not Allow Advertisers to Use My Personal information